These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22310673)

  • 1. Fifth time's the charm?
    Hersher R
    Nat Med; 2012 Feb; 18(2):186. PubMed ID: 22310673
    [No Abstract]   [Full Text] [Related]  

  • 2. Fifth time's the charm for infant respiratory distress drug.
    Katsnelson A
    Nat Biotechnol; 2012 May; 30(5):380. PubMed ID: 22565949
    [No Abstract]   [Full Text] [Related]  

  • 3. Surfactant trials.
    Moya FR; Sinha SK; D'Agostino R
    Pediatrics; 2006 Jan; 117(1):245-7; author reply 247-8. PubMed ID: 16396889
    [No Abstract]   [Full Text] [Related]  

  • 4. Lucinactant approved for respiratory distress syndrome.
    Traynor K
    Am J Health Syst Pharm; 2012 Apr; 69(8):628. PubMed ID: 22472860
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic surfactants: the search goes on.
    Kattwinkel J
    Pediatrics; 2005 Apr; 115(4):1075-6. PubMed ID: 15805389
    [No Abstract]   [Full Text] [Related]  

  • 6. Surfactant respiratory therapy using Surfaxin/sinapultide.
    Lal MK; Sinha SK
    Ther Adv Respir Dis; 2008 Oct; 2(5):339-44. PubMed ID: 19124381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lucinactant for the treatment of respiratory distress syndrome in neonates.
    Piehl E; Fernandez-Bustamante A
    Drugs Today (Barc); 2012 Sep; 48(9):587-93. PubMed ID: 23032799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lucinactant for the prevention of respiratory distress syndrome in premature infants.
    Jordan BK; Donn SM
    Expert Rev Clin Pharmacol; 2013 Mar; 6(2):115-21. PubMed ID: 23473590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrections regarding lucinactant and clinical trials involving lucinactant.
    Clayton RG
    J Perinatol; 2009 Jan; 29(1):72; author reply 73-4. PubMed ID: 19112463
    [No Abstract]   [Full Text] [Related]  

  • 11. Lucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome.
    Donn SM
    Expert Opin Investig Drugs; 2005 Mar; 14(3):329-34. PubMed ID: 15833063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
    Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
    [No Abstract]   [Full Text] [Related]  

  • 13. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolized lucinactant: a potential alternative to intratracheal surfactant replacement therapy.
    Donn SM; Sinha SK
    Expert Opin Pharmacother; 2008 Feb; 9(3):475-8. PubMed ID: 18220497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Criteria for use of colfosceril (Exosurf) in neonates.
    Bhatt-Mehta V; Schumacher RE
    Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary distribution of lucinactant and poractant alfa and their peridosing hemodynamic effects in a preterm lamb model of respiratory distress syndrome.
    Terry MH; Merritt TA; Harding B; Schroeder H; Merrill-Henry J; Mazela J; Gregory TJ; Segal R; Power GG; Blood AB
    Pediatr Res; 2010 Sep; 68(3):193-8. PubMed ID: 20531255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome.
    Wyble L; Santeiro ML
    Ann Pharmacother; 1997 Jun; 31(6):787-8. PubMed ID: 9184726
    [No Abstract]   [Full Text] [Related]  

  • 18. OSIRIS trial.
    Tarnow-Mordi W
    Lancet; 1993 Jan; 341(8838):174. PubMed ID: 8093765
    [No Abstract]   [Full Text] [Related]  

  • 19. Translational research: matching experimental models with therapeutic interventions.
    Shaffer TH; Wolfson MR
    Pediatr Crit Care Med; 2012 May; 13(3):369-70. PubMed ID: 22561272
    [No Abstract]   [Full Text] [Related]  

  • 20. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1990 Oct; 264(14):1802. PubMed ID: 2169534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.